These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 12648888)

  • 1. Four-year outcome in non-compliant schizophrenia patients treated with or without home-based ambulatory outpatient care.
    Kampman O; Illi A; Poutanen P; Leinonen E
    Eur Psychiatry; 2003 Feb; 18(1):1-5. PubMed ID: 12648888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost of relapse in schizophrenia.
    Weiden PJ; Olfson M
    Schizophr Bull; 1995; 21(3):419-29. PubMed ID: 7481573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Specialised first-episode psychosis services: a systematic review of the literature].
    Skalli L; Nicole L
    Encephale; 2011 May; 37 Suppl 1():S66-76. PubMed ID: 21600336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The characteristics and outcomes of hospitalised and outpatient-treated first-onset schizophrenia patients: a 5-year register linkage study.
    Kiviniemi M; Suvisaari J; Isohanni M; Saarento O; Häkkinen U; Pirkola S; Hakko H
    Int J Clin Pract; 2013 Nov; 67(11):1105-12. PubMed ID: 24165424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Six-month outcome following a relapse of schizophrenia.
    Bergen J; Hunt G; Armitage P; Bashir M
    Aust N Z J Psychiatry; 1998 Dec; 32(6):815-22. PubMed ID: 10084346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The European Schizophrenia Outpatient Health Outcomes Study: observational study over 36 months of the French cohort of schizophrenic outpatients treated with antipsychotics].
    Gasquet I; Chartier F; Tcherny-Lessenot S; Lépine JP
    Rev Epidemiol Sante Publique; 2009 Feb; 57(1):25-32. PubMed ID: 19162420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response and relapse in patients with schizophrenia treated with olanzapine, risperidone, quetiapine, or haloperidol: 12-month follow-up of the Intercontinental Schizophrenia Outpatient Health Outcomes (IC-SOHO) study.
    Dossenbach M; Arango-Dávila C; Silva Ibarra H; Landa E; Aguilar J; Caro O; Leadbetter J; Assunção S
    J Clin Psychiatry; 2005 Aug; 66(8):1021-30. PubMed ID: 16086618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness model of long-acting risperidone in schizophrenia in the US.
    Edwards NC; Rupnow MF; Pashos CL; Botteman MF; Diamond RJ
    Pharmacoeconomics; 2005; 23(3):299-314. PubMed ID: 15836010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A pharmacoeconomic model of outpatient antipsychotic therapy in "revolving door" schizophrenic patients.
    Glazer WM; Ereshefsky L
    J Clin Psychiatry; 1996 Aug; 57(8):337-45. PubMed ID: 8752015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. When all else fails: supervised treatment in outpatient for schizophrenia (STOPS).
    Tan HJR
    BMJ Case Rep; 2017 Sep; 2017():. PubMed ID: 28942410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Compliance in schizophrenia: predictive factors, therapeutical considerations and research implications].
    Misdrahi D; Llorca PM; Lançon C; Bayle FJ
    Encephale; 2002; 28(3 Pt 1):266-72. PubMed ID: 12091789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmaco-epidemiological study on antipsychotic drug prescription in French Psychiatry: Patient characteristics, antipsychotic treatment, and care management for schizophrenia].
    Brunot A; Lachaux B; Sontag H; Casadebaig F; Philippe A; Rouillon F; Cléry-Melin P; Hergueta T; Llorca PM; Moreaudefarges T; Guillon P; Lebrun T
    Encephale; 2002; 28(2):129-38. PubMed ID: 11972139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment compliance of outpatients with schizophrenia: patient's attitudes, demographic, clinical and therapeutic variables.
    Stanković Z; Britvić D; Vuković O; Ille T
    Psychiatr Danub; 2008 Mar; 20(1):42-52. PubMed ID: 18376330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison of medical and economic benefits of antipsychotics in the treatment of schizophrenia in France].
    Druais S; Doutriaux A; Cognet M; Godet A; Lançon C; Levy P; Samalin L; Guillon P
    Encephale; 2017 Aug; 43(4):311-320. PubMed ID: 27623123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A trial of compliance therapy in outpatients with schizophrenia or schizoaffective disorder.
    Byerly MJ; Fisher R; Carmody T; Rush AJ
    J Clin Psychiatry; 2005 Aug; 66(8):997-1001. PubMed ID: 16086614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Schizophrenia: attitudes of patients and professional carers towards the illness and antipsychotic medication.
    Rettenbacher MA; Burns T; Kemmler G; Fleischhacker WW
    Pharmacopsychiatry; 2004 May; 37(3):103-9. PubMed ID: 15138893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of combined pharmaco- and psychotherapy in schizophrenia ambulatory care on rehospitalization incidents and treatment costs].
    Müller P; Schöneich D
    Psychiatr Prax; 1992 Jul; 19(4):91-5. PubMed ID: 1354881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness analysis of switching antipsychotic medication to long-acting injectable risperidone in patients with schizophrenia : a 12- and 24-month follow-up from the e-STAR database in Spain.
    Olivares JM; Rodriguez-Martinez A; Burón JA; Alonso-Escolano D; Rodriguez-Morales A;
    Appl Health Econ Health Policy; 2008; 6(1):41-53. PubMed ID: 18774869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Persons suffering from schizophrenia and relapses].
    Passerieux C; Caroli F; Giraud-Baro E
    Encephale; 2009 Dec; 35(6):586-94. PubMed ID: 20004290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A naturalistic, observational study of outpatients with schizophrenia: efficacy and safety results after 6 months. The International Schizophrenia Outpatient Health Outcomes study, IC-SOHO].
    István S; Agoston T; Tamás T; Zoltán J
    Neuropsychopharmacol Hung; 2007 Oct; 9(3):115-24. PubMed ID: 18399029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.